The Journal of Urology
Volume 167, Issue 3 , Pages 1231-1234 , March 2002

EXPECTANT MANAGEMENT OF NONPALPABLE PROSTATE CANCER WITH CURATIVE INTENT: PRELIMINARY RESULTS

,Accepted 14 September 2001.

REFERENCES 

  1. Wilt TJ , Brawer MK . The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. . J Urol . 1994;152:1910
  2. Humphrey PA , Keetch DW , Smith DS , et al.   Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening . J Urol . 1996;155:816
  3. Epstein JI , Walsh PC , Carmichael M , et al.   Pathologic and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer . JAMA . 1994;271:368
  4. Horan AH , McGehee M . Mean time to cancer-specific death of apparently clinically localized prostate cancer: policy implications for threshold ages in prostate-specific antigen screening and ablative therapy. . BJU Int . 2000;85:1063
  5. Carter HB , Sauvageot J , Walsh PC , et al.   Prospective evaluation of men with stage T1c adenocarcinoma of the prostate . J Urol . 1997;157:2206
  6. Epstein JI , Walsh PC , Carter HB . Importance of posterolateral needle biopsies in the detection of prostate cancer. . Urology . 2001;57:1112

 Supported by NCI SPORE CA58236.Editor’s Note:This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1454 and 1455.

PII: S0022-5347(05)65271-8

The Journal of Urology
Volume 167, Issue 3 , Pages 1231-1234 , March 2002